Li Hua, Lü Qing, Xue Hui, Dong Li-hua, Saima Naz, Yang Hui-jun
Department of Anatomy, School of Preclinical and Forensic Medicine, Sichuan University, Chengdu 610041, China.
Nan Fang Yi Ke Da Xue Xue Bao. 2008 Mar;28(3):381-4.
To detect the expression of epidermal fatty acid-binding protein (E-FABP) and fatty acid synthase (FAS) in human breast cancer and identify the potential markers and therapeutic targets for breast cancer.
FAS and E-FABP expressions were detected in 76 patients with infiltrating ductal breast carcinoma using RT-PCR, immunohistochemistry and Western blotting. The possible associations of the expression of the two proteins with the major clinicopathological factors were analyzed.
E-FABP and FAS expression levels were significantly decreased (P<0.05) in grade III as compared with grades I and II infiltrating ductal breast carcinoma. There was a positive correlation between E-FABP and FAS expressions, but their expressions were not correlated to the clinicopathological factors of the patients except for the tumor grades. High E-FABP expression level in grades I and II tumors were associated with an early increased responsiveness to FAS.
The variation of the E-FABP and FAS expressions in the lesions is associated with increase of the risk for breast cancer, and the results of this study provide evidence for developing new molecular markers of high-risk lesions and identifying new the targets for breast cancer therapy.
检测人乳腺癌中表皮脂肪酸结合蛋白(E-FABP)和脂肪酸合酶(FAS)的表达,确定乳腺癌潜在的标志物和治疗靶点。
采用逆转录-聚合酶链反应(RT-PCR)、免疫组织化学和蛋白质免疫印迹法检测76例浸润性导管癌患者中FAS和E-FABP的表达。分析这两种蛋白的表达与主要临床病理因素之间可能存在的关联。
与I级和II级浸润性导管癌相比,III级浸润性导管癌中E-FABP和FAS的表达水平显著降低(P<0.05)。E-FABP和FAS的表达呈正相关,但除肿瘤分级外,它们的表达与患者的临床病理因素无关。I级和II级肿瘤中E-FABP的高表达与FAS早期反应性增加有关。
病变中E-FABP和FAS表达的变化与乳腺癌风险增加相关,本研究结果为开发高危病变的新分子标志物和确定乳腺癌治疗新靶点提供了依据。